Albany Molecular Research, Inc. Contributes to Disaster Relief Funds

Business Wire, Sept 21, 2001

Business Editors

ALBANY, N.Y.--(BUSINESS WIRE)--Sept. 21, 2001

Albany Molecular Research, Inc. (Nasdaq: AMRI) and its employees have donated a total of $120,000 to help those impacted by the September 11 tragedies.

Additionally, the company has donated, through the Albany County Emergency Management Office, respirators to the emergency rescue workers at the World Trade Center.

The donations include both individual employee contributions and matching funds from AMRI. Funds will be distributed to disaster relief organizations such as the American Red Cross, the September 11th Fund established by the United Way of New York City and the New York Community Trust, and the New York State World Trade Center Relief Fund.

"Words cannot describe our feelings for our many friends, fellow citizens and all of those affected by this tragedy," said AMRI Chairman and Chief Executive Officer Thomas E. D'Ambra, Ph.D. "AMRI, its employees and their families, remain ready to continue to support relief efforts and the rebuilding of the confidence and spirit of our community."

Contributions were received from AMRI employees in Albany, Rensselaer and Syracuse, New York; Iowa City, Iowa; and Bothell, Washington.

Albany Molecular Research, Inc. is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.